(in millions, except per share data) | Quarter Ended September 30, 2024 | Full-Year Ended December 31, 2024 | |||||||||||||||||||||||||||||||||
Acquired IPR&D and Milestones Expense | Adjusted Diluted EPS Range | Acquired IPR&D and Milestones Expense | Adjusted Diluted EPS Range | ||||||||||||||||||||||||||||||||
Low | High | Low | High | ||||||||||||||||||||||||||||||||
Previously announced guidance excluding Q3 2024 acquired IPR&D and milestones expense | $ | — | $ | 2.92 | $ | 2.96 | $ | 1,101 | $ | 10.71 | $ | 10.91 | |||||||||||||||||||||||
Q3 2024 acquired IPR&D and milestones expense | 82 | (0.04) | (0.04) | 82 | (0.04) | (0.04) | |||||||||||||||||||||||||||||
Guidance including Q3 2024 acquired IPR&D and milestones expensea | $ | 82 | $ | 2.88 | $ | 2.92 | $ | 1,183 | $ | 10.67 | $ | 10.87 |